Cannabis as Medicine

Those were the words of Minister of Health Ginette Taylor in November 2017, spoken as the government of Canada began to put together Bill 45, known as The Cannabis Act. Over a year has passed since the enactment of Bill 45 and questions still remain regarding the safety of legal cannabis to our pregnant population, […]

FOR RELEASE: September 10, 2019 As part of its regular monitoring of health-related advertising claims, the Federal Trade Commission today sent warning letters to three companies that sell oils, tinctures, capsules, “gummies,” and creams containing cannabidiol (CBD), a chemical compound derived from the cannabis plant. The letters warn the companies, which the FTC is not

Currently, there is no widely available or accepted medical literature showing any benefit for pain with dispensary cannabis in common pain conditions. For full article

How to use evidence to say what you want! Conclusion: When a headline sounds too good to be true, it usually is. There’s nothing in this study to suggest that people should start drinking red wine to lose weight. The potential effect of diet on the micro-organisms in the gut is a new and interesting

Insufficient evidence exists for the use of medical cannabis for most conditions for which its use is advocated, but various US state governments recommended it for over 50 medical conditions, Boston’s Beth Israel Deaconess Medical Center and Harvard Medical School found. The lack of evidence was separately confirmed by NICE in the UK.

JAMA Netw Open. 2019;2(8):e199456. doi:10.1001/jamanetworkopen.2019.9456  Question  Does the number of pediatric cannabis (marijuana) exposure cases before medical marijuana legalization in Massachusetts differ from the number afterward? Findings:  In this repeated cross-sectional study, there were 218 calls related to cannabis exposure received by the Regional Center for Poison Control and Prevention in Massachusetts, constituting 0.15% of all calls concerning

But a new systematic research review from Mayo Clinic, one of the country’s leading medical centers, warns there’s still a lot to learn about CBD. The big takeaway from the review is that no one knows exactly how effective or safe CBD really is. The researchers argue that more research on humans is needed to confirm

The Pharmaceutical Journal Draft guidance says patients with chronic pain should not be offered tetrahydrocannabinol (THC) or mixtures of cannabidiol and THC unless the treatment is part of a clinical trial. The National Institute for Health and Care Excellence (NICE) has said it is currently unable to recommend cannabis-based medical products (CBMPs) for severe treatment-resistant epilepsy. In

Dr Robert L Dupont’s written Testimony to the FDA Regarding the Health Impacts of CBD

A researcher from the University of Houston has found that adults who take prescription opioids for severe pain are more likely to have increased anxiety, depression and substance abuse issues if they also use marijuana. Under the guidance of advisor Michael Zvolensky, Hugh Roy and Lillie Cranz Cullen Distinguished University Professor of psychology and director